RSB on Savage RSB on Savage – 7/19/10 July 19, 2010July 19, 2010 Robert Scott Bell Avandia, diabetes, fda, flexner, Flexner Report, januvia, Merck, michael savage, robert scott bell, rsb, RSB on Savage Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds “What’s a little heart attack among doctors and patients?” If Avandia falls, which diabetes meds fill the gap?
